NCM · Medical - Diagnostics & Research

bioAffinity Technologies, Inc. (BIAF) Stock

$4.85 -14.10% NCM: BIAF Healthcare

Valuation

MetricValue
Price$4.85
Market Cap$2.03M
P/E Ratio-0.05
P/B Ratio0.56
P/S Ratio0.43
EPS (TTM)$0.00
52-Week High$80.70
52-Week Low$4.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-257.27%
ROA-199.30%
ROCE-250.72%
Gross Margin-183.33%
Operating Margin-183.33%
Net Margin-257.33%
Debt/Equity0.38
Current Ratio2.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$3.0M$9.0M$6.0M
Operating Profit$-2.0M$-4.0M$-8.0M$-9.0M$-11.0M
Net Profit$-6.0M$-8.0M$-8.0M$-9.0M$-15.0M
EPS$-1043.55$-814.50$-409.50$-337.50$-129.90
Op Margin—-83511.5%-314.9%-95.6%-171.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$12.0M$8.0M$7.0M$11.0M
Total Liabilities$17.0M$1.0M$3.0M$4.0M$4.0M
Cash$1.0M$11.0M$3.0M$1.0M$6.0M
Borrowings$11.0M$0$2.0M$2.0M$1.0M

Latest News

bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD Business Wire · Jul 22, 2026 BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell? Zacks · Jul 9, 2026 bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues Business Wire · Jul 7, 2026 Q2 Virtual Investor Summit Presentations Now Available On Demand ACCESS Newswire · Jun 30, 2026 Q2 Investor Summit Virtual Live Wednesday June 24 ACCESS Newswire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-4.0M$-6.0M$-7.0M$-9.0M
Investing Cash Flow$0$0$-2.0M$0$0
Financing Cash Flow$0$8.0M$0$1.0M$0
Net Cash Flow$1.0M$10.0M$-9.0M$-2.0M$5.0M
Free Cash Flow$-2.0M$-4.0M$-6.0M$-7.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.10
FCF Yield-453.41%
Quick Ratio1.41
Interest Coverage-276.15
Return 1Y-91.78%
Return 3Y-98.64%
Return 5Y—

Ownership

Insiders Held2.29%
Institutions Held6.44%
Institutions Float Held6.59%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC55,5432026-03-31
Geode Capital Management, LLC48,2932026-03-31
J. Safra Sarasin Holding AG42,6002026-03-31
Vanguard Fiduciary Trust Co31,0712026-03-31
Schonfeld Strategic Advisors Llc24,4132026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $334.89 -1.62% 38.93 $4.92T 0.32%
MSFTMicrosoft Corporation $534.33 +2.24% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $352.51 +1.21% 16.94 $4.27T 0.26%
AMZNAmazon.com, Inc. $260.37 +2.48% 19.82 $2.80T 0.00%
METAMeta Platforms, Inc. $724.78 +0.54% 27.93 $1.85T 0.28%

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. is led by CEO Maria Zannes, publicly traded since 2022.

bioAffinity Technologies, Inc. (BIAF) stock trades at $4.85 with a market capitalization of $2.03M. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of 0.56, price-to-sales of 0.43. Over the past 52 weeks the stock has ranged between $4.56 and $80.70, and currently trades 94.0% below its 52-week high.

On profitability, bioAffinity Technologies, Inc. generates a return on equity (ROE) of -257.27%, return on capital employed of -250.72%, an operating margin of -183.33%, a net profit margin of -257.33%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1176.71 +0.61% JNJ Johnson & Johnson $261.15 +1.82% ABBV AbbVie Inc. $277.39 +1.82% MRK Merck & Company, Inc. Common Stock (new) $146.33 +2.77% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.12 +1.93% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $659.71 +1.19% AMGN Amgen Inc. $415.61 +2.01% GILD Gilead Sciences, Inc. $151.28 +2.84% ABT Abbott Laboratories $99.16 +0.68% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides